They demonstrated that increasing the CD25 mAb PC-61 affinity to activating FcγRs was sufficient to specifically deplete Tregs in the tumor microenvironment and to improve the antitumor effect of mAb alone or in combination with PD-1 mAb (25). Here, IL2RA is linked to neoplasm.